Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:05 PM View:  | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 18-Nov-24 | Private Sale | 526 | $16.03 | $8,433.73 | (2%) 23.71K to 23.18K | |
| 20-May-24 6:30 PM View: | Bair Teresa Brophy Chief Legal Officer | Kura Oncology, Inc. (KURA) | 20-May-24 | Private Sale (Planned) | 2,615 | $22.15 | $57,916.20 | (4%) 71.59K to 68.98K | |
| 31-Jan-24 5:30 PM View: | Dale Stephen Chief Medical Officer | Kura Oncology, Inc. (KURA) | 30-Jan-24 | Sale | 4,825 | $21.55 | $103,980.00 | (11%) 43.64K to 38.82K | |
| 31-Jan-24 5:30 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 29-Jan-24 | Private Sale | 1,496 | $17.80 | $26,629.50 | (6%) 23.1K to 21.6K | |
| 31-Jan-24 5:30 PM View: | Dale Stephen Chief Medical Officer | Kura Oncology, Inc. (KURA) | 29-Jan-24 | Private Sale | 7,158 | $17.80 | $127,416.00 | (14%) 50.8K to 43.64K | |
| 31-Jan-24 5:30 PM View: | Bair Teresa Brophy Chief Legal Officer | Kura Oncology, Inc. (KURA) | 29-Jan-24 | Private Sale | 2,053 | $17.80 | $36,544.40 | (3%) 71.03K to 68.98K | |
| 31-Jan-24 5:30 PM View: | Doyle Thomas James SVP, Finance & Accounting | Kura Oncology, Inc. (KURA) | 29-Jan-24 | Private Sale | 2,318 | $17.80 | $41,261.60 | (5%) 50.91K to 48.59K | |
| 26-Jan-24 5:10 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 24-Jan-24 | Option Exercise | 91,052 | $6.05 | $550,594.00 | 16% 579.75K to 670.8K | |
| 26-Jan-24 5:10 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 24-Jan-24 | Planned Option Sale | 91,052 | $20.23 | $1,841,980.00 | (14%) 670.8K to 579.75K | |
| 04-Jan-24 4:07 PM View: | Bair Teresa Brophy Chief Legal Officer | Kura Oncology, Inc. (KURA) | 02-Jan-24 | Grant | 46,250 | -- | -- | 187% 24.78K to 71.03K | |
| 04-Jan-24 4:08 PM View: | Doyle Thomas James SVP, Finance & Accounting | Kura Oncology, Inc. (KURA) | 02-Jan-24 | Grant | 21,250 | -- | -- | 72% 29.66K to 50.91K | |
| 04-Jan-24 4:07 PM View: | Powl Brian T. Chief Commercial Officer | Kura Oncology, Inc. (KURA) | 02-Jan-24 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 11-Dec-23 4:08 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 07-Dec-23 | Gift | 2,000 | -- | -- | (< 1%) 582.75K to 580.75K | |
| 11-Dec-23 4:08 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 07-Dec-23 | Gift | 1,000 | -- | -- | (< 1%) 580.75K to 579.75K | |
| 21-Jun-23 4:29 PM View: | Malley Thomas Director | Kura Oncology, Inc. (KURA) | 16-Jun-23 | Private Purchase | 50,000 | $11.50 | $575,000.00 | 56% 89.56K to 139.56K | |
| 02-Jun-23 5:06 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 02-Jun-23 | Disposition (other) | 27,966 | -- | -- | (5%) 610.72K to 582.75K | |
| 02-Jun-23 5:06 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 02-Jun-23 | Acquisition (other) | 308,394 | -- | -- | 26% 1.16M to 1.47M | |
| 02-Jun-23 5:06 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 02-Jun-23 | Disposition (other) | 862,212 | -- | -- | (59%) 1.47M to 610.72K | |
| 21-Feb-23 5:08 PM View: | Dale Stephen Chief Medical Officer | Kura Oncology, Inc. (KURA) | 16-Feb-23 | Grant | 23,125 | -- | -- | 84% 27.68K to 50.8K | |
| 21-Feb-23 5:13 PM View: | Bair Teresa Brophy Chief Legal Officer | Kura Oncology, Inc. (KURA) | 16-Feb-23 | Grant | 23,125 | -- | -- | 100% 0 to 23.13K | |
| 21-Feb-23 5:15 PM View: | Doyle Thomas James SVP, Finance & Accounting | Kura Oncology, Inc. (KURA) | 16-Feb-23 | Grant | 10,625 | -- | -- | 61% 17.34K to 27.97K | |
| 31-Jan-23 5:14 PM View: | Doyle Thomas James SVP, Finance & Accounting | Kura Oncology, Inc. (KURA) | 27-Jan-23 | Market Sale | 1,548 | $13.89 | $21,501.80 | (8%) 18.89K to 17.34K | 4% |
| 31-Jan-23 5:17 PM View: | Flowers Kirsten CCO & Chief Strategy Officer | Kura Oncology, Inc. (KURA) | 27-Jan-23 | Market Sale | 1,906 | $13.89 | $26,474.30 | (8%) 22.51K to 20.61K | 4% |
| 31-Jan-23 5:20 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 27-Jan-23 | Market Sale | 1,821 | $13.89 | $25,293.90 | (8%) 23.04K to 21.21K | 4% |
| 31-Jan-23 5:10 PM View: | Dale Stephen Chief Medical Officer | Kura Oncology, Inc. (KURA) | 27-Jan-23 | Market Sale | 9,225 | $13.88 | $128,033.00 | (25%) 36.9K to 27.68K | 4% |
| 18-Nov-22 4:53 PM View: | Bair Teresa Brophy Chief Legal Officer | Kura Oncology, Inc. (KURA) | 17-Nov-22 | Private Sale (Planned) | 2,100 | $15.22 | $31,964.50 | (100%) 2.1K to 0 | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 06-Oct-22 | Disposition (other) | 1,084,300 | -- | -- | (48%) 2.25M to 1.16M | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 06-Oct-22 | Acquisition (other) | 1,084,300 | -- | -- | 93% 1.16M to 2.25M | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 19-Aug-22 | Disposition (other) | 59,026 | -- | -- | (5%) 1.24M to 1.18M | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 19-Aug-22 | Disposition (other) | 11,985 | -- | -- | (1%) 1.18M to 1.16M | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 19-Aug-22 | Acquisition (other) | 41,318 | -- | -- | 3% 1.19M to 1.24M | |
| 21-Feb-23 5:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 14-Jul-22 | Disposition (other) | 468,297 | -- | -- | (28%) 1.66M to 1.19M | |
| 09-Feb-22 5:50 PM View: | Doyle Thomas James SVP, Finance & Accounting | Kura Oncology, Inc. (KURA) | 07-Feb-22 | Grant | 8,390 | -- | -- | 118% 7.11K to 15.5K | |
| 28-Jan-22 4:15 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 26-Jan-22 | Grant | 21,900 | -- | -- | 1930% 1.14K to 23.04K | |
| 28-Jan-22 4:10 PM View: | Dale Stephen Chief Medical Officer | Kura Oncology, Inc. (KURA) | 26-Jan-22 | Grant | 36,900 | -- | -- | 100% 0 to 36.9K | |
| 28-Jan-22 4:17 PM View: | Grasso Marc CFO, CBO | Kura Oncology, Inc. (KURA) | 26-Jan-22 | Grant | 21,900 | -- | -- | 100% 0 to 21.9K | |
| 28-Jan-22 4:13 PM View: | Flowers Kirsten Chief Commercial Officer | Kura Oncology, Inc. (KURA) | 26-Jan-22 | Grant | 21,900 | -- | -- | 3584% 0.61K to 22.51K | |
| 17-Mar-21 4:17 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 15-Mar-21 | Market Option Sale (Planned) | 6,250 | $29.43 | $183,951.00 | (100%) 6.25K to 0 | |
| 17-Mar-21 4:17 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 15-Mar-21 | Option Exercise | 6,250 | $19.43 | $121,438.00 | 100% 0 to 6.25K | |
| 28-Jan-21 5:16 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 23-Dec-20 | Disposition (other) | 175,000 | -- | -- | (10%) 1.83M to 1.66M | |
| 16-Dec-20 4:02 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 15-Dec-20 | Market Option Sale (Planned) | 9,375 | $40.60 | $380,667.00 | (100%) 9.38K to 0 | 11% |
| 16-Dec-20 4:02 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 15-Dec-20 | Option Exercise | 9,375 | $19.43 | $182,156.00 | 100% 0 to 9.38K | (5%) |
| 02-Dec-20 4:04 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 01-Dec-20 | Option Exercise | 11,855 | $6.15 | $72,908.20 | < 1% 1.82M to 1.83M | |
| 12-Nov-20 5:02 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 10-Nov-20 | Option Exercise | 6,250 | $19.43 | $121,438.00 | 100% 0 to 6.25K | (5%) |
| 12-Nov-20 5:02 PM View: | Ford Kathleen Chief Operating Officer | Kura Oncology, Inc. (KURA) | 10-Nov-20 | Market Option Sale (Planned) | 6,250 | $39.43 | $246,438.00 | (100%) 6.25K to 0 | 9% |
| 08-Oct-20 6:55 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 08-Oct-20 | Market Sale (Planned) | 50,370 | $34.00 | $1,712,580.00 | (3%) 1.87M to 1.82M | (6%) |
| 08-Oct-20 6:55 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 08-Oct-20 | Market Option Sale (Planned) | 45,784 | $34.00 | $1,556,660.00 | (2%) 1.98M to 1.93M | (6%) |
| 08-Oct-20 6:55 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 08-Oct-20 | Market Sale (Planned) | 60,952 | $34.00 | $2,072,370.00 | (3%) 1.93M to 1.87M | (6%) |
| 08-Oct-20 6:55 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 08-Oct-20 | Option Exercise | 50,370 | $6.15 | $309,776.00 | 3% 1.93M to 1.98M | |
| 08-Oct-20 6:55 PM View: | Wilson Troy Edward President and CEO Director | Kura Oncology, Inc. (KURA) | 07-Oct-20 | Market Option Sale (Planned) | 4,586 | $34.00 | $155,924.00 | (< 1%) 1.93M to 1.93M | (6%) |
